Your browser doesn't support javascript.
loading
Two-year surveillance on fluconazole susceptibility of Candida spp isolates in a general and university hospital in Rome.
Testore, G P; Falco, F; Sarrecchia, C; Sordillo, P; Bontempo, G; Andreoni, M.
Afiliação
  • Testore GP; University of Rome Tor Vergata, Department of Public Health, Rome, Italy.
Diagn Microbiol Infect Dis ; 41(1-2): 23-7, 2001.
Article em En | MEDLINE | ID: mdl-11687310
ABSTRACT
Fluconazole susceptibility was tested in 385 clinical yeast isolates (285 Candida albicans, 38 C. glabrata, 31 C. tropicalis, 31 other Candida subsp.) using the agar disk diffusion test. Yeasts were collected from specimens obtained from outpatients (69) and inpatients (intensive care unit 79 isolates, major burn unit 31 isolates, hematology ward 45 isolates, gynecology ward 67 isolates, other wards 94 isolates). Three hundred and fifty-six (92%) yeast isolates showed to be susceptible, 18 (5%) were susceptible dose-dependent, and 10 (3%) were resistant to fluconazole. Of the resistant group, 3 isolates were C.albicans, while seven were Candida non-albicans (2 C. rugosa, 2 C. humicola, 1 C. tropicalis, 1 C. ciferrii, 1 C. glabrata). The disk-diffusion method was easy to perform and there were no difficulties in the interpretation of inhibition zone diameters. Fluconazole maintained a good activity against Candida spp despite its extensive use for the prophylaxis and treatment of fungal infections.
Assuntos
Buscar no Google
Base de dados: MEDLINE Assunto principal: Candida / Fluconazol / Antifúngicos Tipo de estudo: Screening_studies Limite: Humans País como assunto: Europa Idioma: En Ano de publicação: 2001 Tipo de documento: Article
Buscar no Google
Base de dados: MEDLINE Assunto principal: Candida / Fluconazol / Antifúngicos Tipo de estudo: Screening_studies Limite: Humans País como assunto: Europa Idioma: En Ano de publicação: 2001 Tipo de documento: Article